Adverse Event Reporting
| VAERS ID | 910421 |
|---|---|
| Gender | Male |
| Age | |
| StateCode | FR |
| Pharmaceutical Company | PFIZER\BIONTECH |
| Lot Number | E50553 |
| Number of vaccinations | |
| Vaccinated | 2020-12-08 |
| Onset | 2020-12-01 |
| Condition | Permanent Disability |
Symptoms
- Pain in extremity
- Headache
- Myalgia
- SARS-CoV-2 test
- Lethargy
Current Illness
Preexisting Conditions
Comments: No past medical history. Patient has not had symptoms associated with COVID-19. Patient is not enrolled in clinical trial. List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
Other Medications
Previous Vaccinations
Allergies
Laboratory Data
Test Date: 20201213; Test Name: COVID-19 virus test; Result Unstructured Data: Test Result:had not tested positive for COVID-19
Write-up
Lethargy; Headache; Aches & pains in legs; Generalised muscle aches / a full body muscular ache; This is a spontaneous report downloaded from the Regulatory Authority WEB, GB-MHRA-APPCOVID-20201213104101 and GB-MHRA-ADR 24542735.
A contactable other healthcare professional reported that a 26-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: E50553), via an unspecified route of administration on 08Dec2020 at a single dose for covid-19 vaccination.
It was given in the hospital.
The patient's had no past medical history.
Patient has not had symptoms associated with COVID-19.
Patient is not enrolled in clinical trial.
Concomitant medications were not reported.
On 09Dec2020, the patient experienced aches & pains in legs.
It began as generalised headache and progressed to lethargy both on 10Dec2020 and generalised muscle aches/a full body muscular ache on an unspecified date in Dec2020.
The patient underwent lab tests and procedures which included COVID-19 virus test: had not tested positive for COVID-19 on 13Dec2020 since having the vaccine.
Outcome of the headache was recovering, while of the myalgia was unknown, while of the remaining events was not recovered.
The events were considered serious due to disability criterion.
No follow-up attempts are possible.
No further information is expected.